Zobrazeno 1 - 4
of 4
pro vyhledávání: '"J M Larranaga"'
Autor:
M J Azpiroz Franch, G Casas Masnou, A Romero, M I Gonzalez Del Hoyo, J M Larranaga Moreira, R Escalona Silva, A Guala, J Limeres Freire, A Bayes De Luna, E Zorio Grima, E Villacorta Arguelles, P Garcia Pavia, R Barriales Villa, I Ferreira Gonzalez, J F Rodriguez Palomares
Publikováno v:
European Heart Journal. 43
Introduction Left ventricular non compaction (LVNC) is a heterogeneous entity with uncertain prognosis. Cardiac magnetic resonance (CMR) is widely used in the diagnosis of LVNC. However, its role in risk stratification has not been well established.
Autor:
G Teixido Tura, D Martinez, F Calvo, R Garcia-Orta, R Sanchez, J M Larranaga, A Hernandiz, E Diaz, E Montanes, F Cabrera, A Sabate, F Nistal, A Forteza, A Evangelista
Publikováno v:
European Heart Journal. 43
Background LDS is a rare disease due to genetic variants in the TGFB pathway. Limited information is available regarding the overall aortic and vascular outcome of these patients Purpose To evaluate aortic and vascular complications of patients with
Autor:
M Gonzalez Del Hoyo, G Casas Masnou, A Romero, M J Azpiroz-Franch, J M Larranaga Moreira, R A Escalona Silvina, A Guala, J Limeres Freire, A Bayes De Luna, E Zorio Grima, E Villacorta Arguelles, P Garcia Pavia, I Barriales Villa, I Ferreira Gonzalez, J F Rodriguez Palomares
Publikováno v:
European Heart Journal. 43
Introduction Left ventricular noncompaction (LVNC) is a poorly defined entity with LV ejection fraction (LVEF) being the main predictor of major adverse cardiovascular events (MACE). Left ventricular hemodynamic forces (LVHDF) have been recently demo
Autor:
P. J. M. Larranaga, F. C. Benham
Publikováno v:
The Economic Journal. 43:290